August 2026– date –
-
iRhythm Acquires VitalConnect for $287.5 Million, Expanding Wearable Multi-Parameter Cardiac Monitoring Platform
G-MedTech America Overview iRhythm has entered a definitive agreement to acquire VitalConnect, a leader in wearable biosensor technology and ambulatory cardiac monitoring, for approximately $287.5 million. VitalConnect's FDA-cleared plat... -
CUREator+ Funds Six Australian Healthtech Startups with $13.5 Million to Accelerate AI Diagnostics and Digital Health Tool Development
Biotech Dispatch Australia Overview CUREator+ has provided a total of $13.5 million in funding to six Australian healthtech startups through its second funding round. This capital aims to accelerate the development and commercialization ... -
UT Dallas, MIT, and Tufts Universities Unveil Groundbreaking Sensor Technologies for Food Safety, Cancer/HIV Diagnostics, and Real-time Intake Monitoring
UT Dallas (via Facebook) America Overview UT Dallas developed the WaveFlex sensor utilizing nanomaterials like CeO2-NRs for Shigella detection in food. MIT researchers introduced a 50-cent CRISPR-based disposable DNA sensor for detecting... -
Abbott Secures CE Mark for Libre Duo Glucose-Ketone Sensor, Accelerates European Rollout of Consumer Lingo Biosensor
FreeStyle Libre Summer 2026 update Europe Overview Abbott obtained the European CE Mark in May 2026 for Libre Duo and Libre Duo 10 Day, capable of measuring both glucose and ketones for 15 days, with European market launch planned within... -
Non-Invasive Optical Glucose Sensing Advances with In Vivo Raman Platform Validation for Real-World Reliability: 2026 Research Unveiled
Sweet Light Global Overview Despite extensive research and investment, non-invasive optical glucose monitoring lacks FDA-approved products, but a 2026 study validated an in vivo Raman platform in oral glucose tolerance tests, marking sig... -
Abbott and Google Health Announce Multi-Year Partnership to Revolutionize Personal Metabolic Health Management with AI-Powered Glucose Insights
PR Newswire USA Overview Abbott and Google Health have announced a multi-year partnership to integrate glucose insights from Abbott's Lingo biowearables with Google's AI and consumer technology, aiming to make personalized metabolic heal... -
Abbott and Medtronic Announce Global Partnership to Integrate FreeStyle Libre CGM Technology into Medtronic Insulin Delivery Systems
Abbott (via Facebook press release), Medtronic USA Overview Medtronic and Abbott have announced a global partnership to integrate Abbott's FreeStyle Libre sensing technology into Medtronic's insulin delivery systems. Under this agreement... -
FDA Approves Non-Invasive Biomarker Imaging Technology for Early Cardiovascular Disease Detection with 98.4% Sensitivity via Retinal Scan
news-today.us USA Overview The FDA has approved a groundbreaking non-invasive biomarker imaging technology capable of detecting subtle vascular inflammation during routine health check-ups. This optical biosensor platform achieves 98.4% ... -
Dexcom Stelo Wins FDA Approval as First Prescription-Free OTC Continuous Glucose Monitor for Non-Insulin Users
Dexcom (via Facebook) USA Overview Dexcom's Stelo glucose biosensor system has received FDA approval as the first over-the-counter (OTC) continuous glucose monitor (CGM) for adults aged 18 and older who do not use insulin. This landmark ... -
High-Accuracy Growth-Coupled Metabolic Biosensor Achieves 0.88-1.00 Precision in COVID-19 Prognosis and Diagnosis
bioRxiv USA Overview A novel workflow has successfully engineered and characterized growth-coupled metabolic biosensors demonstrating high accuracy for disease prognosis and diagnosis, exemplified with COVID-19. The top-performing sensor...
